BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 31229536)

  • 1. Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress.
    Lin J; Fang L; Li H; Li Z; Lyu L; Wang H; Xiao J
    Eur J Pharmacol; 2019 Sep; 859():172490. PubMed ID: 31229536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of valsartan administration on doxorubicin‑induced myocardial injury in rats and the role of oxidative stress and NOX2/NOX4 signaling.
    Cheng D; Chen L; Tu W; Wang H; Wang Q; Meng L; Li Z; Yu Q
    Mol Med Rep; 2020 Nov; 22(5):4151-4162. PubMed ID: 33000246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
    Jia Y; Zuo D; Li Z; Liu H; Dai Z; Cai J; Pang L; Wu Y
    Chem Pharm Bull (Tokyo); 2014; 62(1):45-53. PubMed ID: 24390491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2.
    McLaughlin D; Zhao Y; O'Neill KM; Edgar KS; Dunne PD; Kearney AM; Grieve DJ; McDermott BJ
    Br J Pharmacol; 2017 Nov; 174(21):3677-3695. PubMed ID: 28261787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17β-estradiol protects against doxorubicin-induced cardiotoxicity in male Sprague-Dawley rats by regulating NADPH oxidase and apoptosis genes.
    Zhang XJ; Cao XQ; Zhang CS; Zhao Z
    Mol Med Rep; 2017 May; 15(5):2695-2702. PubMed ID: 28447737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction.
    Tian XQ; Ni XW; Xu HL; Zheng L; ZhuGe DL; Chen B; Lu CT; Yuan JJ; Zhao YZ
    Int J Nanomedicine; 2017; 12():7103-7119. PubMed ID: 29026304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium isoglycyrrhizinate alleviates fructose-induced liver oxidative stress and inflammatory injury through suppressing NOXs.
    Yang YZ; Liu ZH; Wang SC; Zhang XQ; Xu HJ; Yang L; Kong LD
    Eur J Pharmacol; 2020 Sep; 883():173314. PubMed ID: 32619679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis.
    Zhang P; Lu H; Wu Y; Lu D; Li C; Yang X; Chen Z; Qian J; Ge J
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
    van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
    J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Kininogen-1 aggravates oxidative stress and mitochondrial dysfunction in DOX-induced cardiotoxicity.
    Cheng X; Liu D; Song H; Tian X; Yan C; Han Y
    Biochem Biophys Res Commun; 2021 Apr; 550():142-150. PubMed ID: 33706097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1 - mediated mitochondrial dysfunction.
    Zhuang X; Sun X; Zhou H; Zhang S; Zhong X; Xu X; Guo Y; Xiong Z; Liu M; Lin Y; Zhang M; Liao X
    Mech Ageing Dev; 2021 Apr; 195():111442. PubMed ID: 33539906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress.
    Yang N; Ma H; Jiang Z; Niu L; Zhang X; Liu Y; Wang Y; Cheng S; Deng Y; Qi H; Wang Z
    Biochem Biophys Res Commun; 2019 Sep; 517(1):111-117. PubMed ID: 31303273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV Prevents Cardiac Remodeling in the Apolipoprotein E-Deficient Mice by Regulating Cardiac Homeostasis and Oxidative Stress.
    Li XZ; Ding YZ; Wu HF; Bian ZP; Xu JD; Gu CR; Chen XJ; Yang D
    Cell Physiol Biochem; 2017; 44(6):2422-2438. PubMed ID: 29268252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of cardiomyopathy induced by doxorubicin in rats.
    Medeiros-Lima DJM; Carvalho JJ; Tibirica E; Borges JP; Matsuura C
    Pharmacol Rep; 2019 Aug; 71(4):583-590. PubMed ID: 31174019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV reversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice.
    Xu N; Kan P; Yao X; Yang P; Wang J; Xiang L; Zhu Y
    J Microbiol; 2018 Nov; 56(11):838-846. PubMed ID: 30353470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
    Mantawy EM; El-Bakly WM; Esmat A; Badr AM; El-Demerdash E
    Eur J Pharmacol; 2014 Apr; 728():107-18. PubMed ID: 24509133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP-2 mediates cardiomyocyte aging and damage induced by doxorubicin through SIRT1 Inhibition.
    Huang C; Zhang X; Wang S; Shen A; Xu T; Hou Y; Gao S; Xie Y; Zeng Y; Chen J; Lin R; Zhang Y; Wan C; Cai Y
    Apoptosis; 2024 Jun; 29(5-6):816-834. PubMed ID: 38281279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study on beneficial effects of vitamins B and D in attenuating doxorubicin induced cardiotoxicity in rats: Emphasis on calcium homeostasis.
    Awad HH; El-Derany MO; Mantawy EM; Michel HE; El-Naa MM; Salah El-Din RA; El-Brairy AI; El-Demerdash E
    Biomed Pharmacother; 2021 Aug; 140():111679. PubMed ID: 34029952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSCs enhances the protective effects of valsartan on attenuating the doxorubicin-induced myocardial injury via AngII/NOX/ROS/MAPK signaling pathway.
    Cheng D; Tu W; Chen L; Wang H; Wang Q; Liu H; Zhu N; Fang W; Yu Q
    Aging (Albany NY); 2021 Sep; 13(18):22556-22570. PubMed ID: 34587120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress.
    Wang Y; Lei T; Yuan J; Wu Y; Shen X; Gao J; Feng W; Lu Z
    Redox Biol; 2018 Jul; 17():25-34. PubMed ID: 29660505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.